Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00213148
Status:
COMPLETED
Last Update Posted:
2018-07-17
First Post:
2005-09-13
Brief Title:
Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction
Sponsor:
EMD Serono
Organization:
EMD Serono
Study Overview
Official Title:
A Phase II Prospective Randomized Double-Blind Multicenter Dose Finding Comparative Study for the Evaluation of the Aromatase Inhibitor Anastrozole Multiple-Dose Versus Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction
Status:
COMPLETED
Status Verified Date:
2017-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate and compare the safety and efficacy of various doses of the aromatase inhibitor anastrozole versus clomiphene citrate in stimulating follicular growth and ovulation in infertile women with ovulatory dysfunction
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None